AlphaMark Advisors, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 169 filers reported holding GW PHARMACEUTICALS PLC in Q4 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
AlphaMark Advisors, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2019$9,000
-25.0%
89
-14.4%
0.00%
-20.0%
Q3 2019$12,000
-33.3%
1040.0%0.01%
-37.5%
Q2 2019$18,0000.0%1040.0%0.01%0.0%
Q1 2019$18,000
+80.0%
1040.0%0.01%
+60.0%
Q4 2018$10,000
-44.4%
1040.0%0.01%
-28.6%
Q3 2018$18,000
+20.0%
1040.0%0.01%
+16.7%
Q2 2018$15,000
+50.0%
104
+16.9%
0.01%
+50.0%
Q1 2018$10,000
-16.7%
890.0%0.00%
-20.0%
Q4 2017$12,000
+33.3%
890.0%0.01%
+25.0%
Q3 2017$9,0000.0%890.0%0.00%0.0%
Q2 2017$9,000
-18.2%
890.0%0.00%
-20.0%
Q1 2017$11,000
+10.0%
890.0%0.01%0.0%
Q4 2016$10,000
-16.7%
890.0%0.01%
-16.7%
Q3 2016$12,000
+50.0%
890.0%0.01%
+20.0%
Q2 2016$8,000
+33.3%
890.0%0.01%
+66.7%
Q1 2016$6,0000.0%890.0%0.00%0.0%
Q4 2015$6,000
-25.0%
890.0%0.00%
-25.0%
Q3 2015$8,000890.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2016
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders